Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

NCT07565428 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Negative Symptoms of Schizophrenia

Interventions

DRUG: Roluperidone
DRUG: risperidone
DRUG: aripiprazole
DRUG: olanzapine
DRUG: Placebo

Sponsor

Minerva Neurosciences